Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis.

Dhan Bahadur Shrestha Pravash Budhathoki Sitaram Khadka Prajwol Bikram ShahNisheem PokharelPrama Rashmi

Published in: Virology journal (2020)

There is a significant clinical and radiological improvement following treatment with FVP in comparison to the standard of care with no significant differences on viral clearance, oxygen support requirement and side effect profiles.

Keyphrases

healthcare
palliative care
coronavirus disease
quality improvement
pain management
chronic pain
affordable care act
replacement therapy